Show simple item record

FieldValueLanguage
dc.contributor.authorBusse, Madleen
dc.contributor.authorWindsor, Madeline S. A.
dc.contributor.authorTefay, Alexander J.
dc.contributor.authorKardashinsky, Mingyue
dc.contributor.authorFenton, Jacob M.
dc.contributor.authorMorrison, Daniel E.
dc.contributor.authorHarris, Hugh H.
dc.contributor.authorRendina, Louis M.
dc.date.accessioned2019-12-20
dc.date.available2019-12-20
dc.date.issued2017-12-01
dc.identifier.citationJournal of Inorganic Biochemistry 177 (2017) 313–321314en
dc.identifier.urihttps://hdl.handle.net/2123/21605
dc.description.abstractThe synthesis of a series of bifunctional Gd(III) complexes 1–3 covalently bound to arylphosphonium cations possessing a varying degree of delocalisation at the phosphonium centre is presented. The influence of the degree of delocalisation was investigated with regards to in vitro cytotoxicity, cellular uptake of Gd, tumor-cell selectivity and intracellular localisation of Gd within human glioblastoma (T98G) and human glial (SVG p12) cells. Cellular uptake and selectivity studies for the Gd(III) complexes indicate that a reduced delocalisation at the phosphonium centre can lead to an enhanced Gd uptake into SVG p12 cells which results in a decrease in the overall tumor cell selectivity. Synchrotron X-ray fluorescence (microbeam XRF) imaging has demonstrated for the first time that uniform uptake of Gd(III) complex 2 within a population of T98G cells increased as a function of increasing Gd incubation times. The Gd maps show dispersed spots of high intensity which are consistent with mitochondrial uptake.en
dc.description.sponsorshipAustralian Research Council (ARC DP120100958 and ARC DP140100176)en
dc.language.isoenen
dc.publisherElsevieren
dc.relationARC DP120100958en
dc.rightsOtheren
dc.subjectmitochondriaen
dc.subjectgadoliniumen
dc.subjectphosphoniumen
dc.subjectglioblastomaen
dc.subjectXRF imagingen
dc.titleTumor cell uptake and selectivity of gadolinium(III)-phosphonium complexes: The role of delocalisation at the phosphonium centreen
dc.typeArticleen
dc.subject.asrcFoR::030201 - Bioinorganic Chemistryen
dc.subject.asrcFoR::030299 - Inorganic Chemistry not elsewhere classifieden
dc.subject.asrcFoR::111204 - Cancer Therapy (excl. Chemotherapy and Radiation Therapy)en
dc.subject.asrcFoR::110302 - Clinical Chemistry (diagnostics)en
dc.identifier.doi10.1016/j.jinorgbio.2017.07.004
dc.type.pubtypeAuthor accepted manuscripten
usyd.facultyFaculty of Science, School of Chemistry


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.